Gene2011
MARK2: microtubule affinity regulating kinase 2
Cite this record
ConductScience Library. MARK2: microtubule affinity regulating kinase 2. Genes, record 2011. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/2011
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q7KZI7 | Serine/threonine-protein kinase MARK2 | 788 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents48
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 52609 | Q7KZI7 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 6600 | Q7KZI7 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 6600 | Q7KZI7 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 36453 | Q7KZI7 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 52609 | Q7KZI7 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 31767 | Q7KZI7 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 49195 | Q7KZI7 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 49195 | Q7KZI7 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 49195 | Q7KZI7 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 152166 | Q7KZI7 | Espacenet |
NIH grants1,033
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MARK2 papers | Newest fiscal year |
|---|---|---|---|
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 7 | 2025 |
| P01CA116087 | H. pylori-induced Inflammation and Gastric Cancer | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| R01CA077955 | H. Pylori Relationship to Digestive Diseases and Cancer | 6 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 4 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
Source NIH's project files
Papers1,061
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lineage-Specific CagA Binding Mechanics and Microenvironmental Rewiring in East Asian Gastric Carcinogenesis. | Molecules | 2026 | 42738777 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations. | Cell Rep | 2026 | 42726641 | PubTator, text mining | PubMed |
| NAT10 promotes prostate cancer progression by acetylating mRNA of MARK2 and activating mTOR/HIF-1α/C-Myc pathway to enhance glycolytic reprogramming. | Cancer Gene Ther | 2026 | 42629368 | PubTator, text mining | PubMed |
| Case Report: Epileptic phenotype in a patient with a MARK2 variant: the first detailed description and review of the literature. | Front Pediatr | 2026 | 42255910 | PubTator, text mining | PubMed |
| PhosSight: A Unified Deep Learning Framework Boosting and Accelerating Phosphoproteome Identification to Enable Biological Discoveries. | Adv Sci (Weinh) | 2026 | 42201678 | PubTator, text mining | PubMed |
| Targeting of MARK2, but not other MARKs, suppresses TNBC progression by inhibition of the mutant p53-driven signaling pathway. | Chin J Nat Med | 2026 | 42019995 | PubTator, text mining | PubMed |
| Deleterious coding variation associated with autism is shared across ancestries. | Nat Med | 2026 | 41912808 | PubTator, text mining | PubMed |
| Discovery of MARK2 as a physiological kinase for PER2 in the mammalian clock. | Cell Chem Biol | 2026 | 41812650 | PubTator, text mining | PubMed |
| MRCKα represses GEF-H1 mediated RhoA activation to promote ovarian cancer spheroid growth and invasion. | bioRxiv | 2026 | 41726953 | PubTator, text mining | PubMed |
| Ligand-Based Pharmacophore Mapping and Virtual Screening for the Search of Biguanide-Like Molecules With Antidiabetic Potentials Targeting Liver Kinase B1. | Biochem Res Int | 2026 | 41725923 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2011
GET https://conductscience.org/api/genes/v1/2011/patents?page=2